Literature DB >> 29203054

On the Search to Elucidate the Role of Microbiota in the Genesis of Cancer: The Cases of Gastrointestinal and Cervical Cancer.

Francisco Avilés-Jiménez1, Guoqin Yu2, Kirvis Torres-Poveda3, Vicente Madrid-Marina4, Javier Torres5.   

Abstract

The microbiota that inhabits the human body plays an important role in health and disease, by their fundamental role in food digestion, training of the immune system or protection against pathogen colonization. However, when the equilibrium with its host is altered, some diseases like cancer might be promoted. In this review we describe the information collected in recent studies between the microbiota and its association with cancer. We conducted the review of the relation of microbiome and cancer etiology focusing on the gastrointestinal and cervical cancer. The MEDLINE database was used for the search. The gastrointestinal tract harbours a diverse and site specific microbiota, and several studies have demonstrated that perturbation of these microbial communities might be associated with different types of cancer. In particular, alteration of the colorectal, gastric and oesophageal microbiota have been reported associated with cancer development. Likewise, cervical microbiome studies suggest that some members of the cervical microbiota are possible modifiers of the cytokine profile of the cervical microenvironment during the development of cervical lesions and cervical cancer. Larger prospective studies are needed to examine whether microbiome dysbiosis could cause cancer, and to evaluate the utility of microbiome profiles as biomarkers for prevention and early diagnosis. This is an important area of research if we consider that microbiota may be a modifiable factor by the use of pre- and probiotics, in order to prevent cancer evolution or even to potentiate cancer treatment.
Copyright © 2017 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Gastrointestinal cancer; Microbiome; Microbiota

Mesh:

Year:  2017        PMID: 29203054     DOI: 10.1016/j.arcmed.2017.11.008

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  6 in total

1.  Overexpression of SMC4 predicts a poor prognosis in cervical cancer and facilitates cancer cell malignancy phenotype by activating NF-κB pathway.

Authors:  Hui He; Cui Zheng; Yunxian Tang
Journal:  Hum Cell       Date:  2021-09-03       Impact factor: 4.174

Review 2.  Diet, Microbes, and Cancer Across the Tree of Life: a Systematic Review.

Authors:  Stefania E Kapsetaki; Gissel Marquez Alcaraz; Corrie M Whisner; Athena Aktipis; Carlo C Maley
Journal:  Curr Nutr Rep       Date:  2022-06-15

Review 3.  The Immune Microenvironment in Human Papilloma Virus-Induced Cervical Lesions-Evidence for Estrogen as an Immunomodulator.

Authors:  Jayshree R S
Journal:  Front Cell Infect Microbiol       Date:  2021-04-30       Impact factor: 5.293

4.  Compositional and Functional Differences between Microbiota and Cervical Carcinogenesis as Identified by Shotgun Metagenomic Sequencing.

Authors:  Minji Kwon; Sang-Soo Seo; Mi Kyung Kim; Dong Ock Lee; Myoung Cheol Lim
Journal:  Cancers (Basel)       Date:  2019-03-05       Impact factor: 6.639

5.  Vaginal Microbiota Changes Caused by HPV Infection in Chinese Women.

Authors:  Yichan Zhang; Xiaolin Xu; Liqun Yu; Xingxian Shi; Min Min; Lijuan Xiong; Jia Pan; Yong Zhang; Peipei Liu; Guizhen Wu; Guolan Gao
Journal:  Front Cell Infect Microbiol       Date:  2022-06-21       Impact factor: 6.073

6.  Signatures of oral microbiome in HIV-infected individuals with oral Kaposi's sarcoma and cell-associated KSHV DNA.

Authors:  Marion Gruffaz; Tinghe Zhang; Vickie Marshall; Priscila Gonçalves; Ramya Ramaswami; Nazzarena Labo; Denise Whitby; Thomas S Uldrick; Robert Yarchoan; Yufei Huang; Shou-Jiang Gao
Journal:  PLoS Pathog       Date:  2020-01-17       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.